These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22888604)

  • 21. Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in vitro testing.
    Brake DA; McIlhaney M; Miller T; Christianson K; Keene A; Lohnas G; Purcell C; Neilan J; Schutta C; Barrera J; Burrage T; Brough DE; Butman BT
    Dev Biol (Basel); 2012; 134():123-33. PubMed ID: 22888605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The reduction of the use of challenge testing to provide evidence of efficacy in tests of immunological veterinary medicinal products (IVMPs).
    Webster CJ
    Dev Biol Stand; 1996; 86():103-9. PubMed ID: 8785938
    [No Abstract]   [Full Text] [Related]  

  • 23. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
    Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
    Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AlphaLISA assays to improve the vaccine development process.
    Cosentino G
    Dev Biol (Basel); 2012; 134():107-11. PubMed ID: 22888602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developments in the reduction refinement and replacement of animal tests in the quality control of immunobiologicals.
    Kreeftenberg JG
    Dev Biol Stand; 1999; 101():13-7. PubMed ID: 10566769
    [No Abstract]   [Full Text] [Related]  

  • 26. Veterinary vaccines: In-VITRO--International Veterinary Industry Test Replacement Organisation.
    Redhead K; Lucken R; van de Moer A; Houghton S; Simpson B; Cameron A; Monkton P; Hennesy K; Ellis C
    Dev Biol Stand; 1999; 101():261-6. PubMed ID: 10566800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rat immunogenicity assay of inactivated poliovirus.
    Bevilacqua JM; Young L; Chiu SW; Sparkes JD; Kreeftenberg JG
    Dev Biol Stand; 1996; 86():121-7. PubMed ID: 8785941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternatives and developing countries.
    Milstien JB; Dellepiane N
    Dev Biol Stand; 1999; 101():203-8. PubMed ID: 10566794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory requirements for vaccine authorisation.
    Jones PG; Cowan G; Gravendyck M; Nagata T; Robinson S; Waits M
    Rev Sci Tech; 2007 Aug; 26(2):379-93. PubMed ID: 17892159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Researching hard to reach areas of knowledge: qualitative research in veterinary science.
    Christley RM; Perkins E
    Equine Vet J; 2010 May; 42(4):285-6. PubMed ID: 20525043
    [No Abstract]   [Full Text] [Related]  

  • 31. Call to curb lab tests on dogs.
    Turner M
    Nature; 2011 Jun; 474(7353):551. PubMed ID: 21720337
    [No Abstract]   [Full Text] [Related]  

  • 32. Harmonization of testing requirements for veterinary vaccines.
    Bellinzoni R
    Dev Biol (Basel); 2004; 119():381-2. PubMed ID: 15742650
    [No Abstract]   [Full Text] [Related]  

  • 33. [The development and approval of alternative methods to bioassays used for quality assurance, a challenge for the pharmaceutical industry and the authorities].
    Miethe G; Sponer G
    ALTEX; 2002; 19(3):115-21. PubMed ID: 12165813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opportunities to reduce the use of animals in the potency and toxicity testing of toxoid vaccines.
    Knight PA
    Dev Biol Stand; 1996; 86():185-97. PubMed ID: 8785948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cost of quality assurance/quality control.
    Johnson DW
    Dev Biol Stand; 1992; 79():193-200. PubMed ID: 1286758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potency tests of diphtheria, tetanus and combined vaccines. Suggestion for a simplified potency assay.
    Aggerbeck H; Heron I
    Dev Biol Stand; 1996; 86():297-301. PubMed ID: 8785958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preface: challenges and issues in veterinary pharmacology and animal health - 2005.
    Martinez M; Soback S
    AAPS J; 2005 Sep; 7(2):E266-71. PubMed ID: 16353907
    [No Abstract]   [Full Text] [Related]  

  • 38. [Development of alternative methods by the EDQM and the Biological Standardization Program].
    Buchheit KH
    ALTEX; 2001; 18(1):19-22. PubMed ID: 11248845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FEDESA's point of view: quality, application to IVMPs (immunological veterinary medicinal products).
    Soulebot JP
    Dev Biol Stand; 1992; 79():201-11. PubMed ID: 1286759
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation and validation of a single-dilution potency assay based upon serology of vaccines containing diphtheria toxoid: analysis for consistency in production and testing.
    Akkermans AM; Hendriksen CF; Marsman FR; van de Donk HJ
    Dev Biol Stand; 1996; 86():323-4. PubMed ID: 8785964
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.